Trial · NCT02851797
Results by group86
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 86
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in 4 Standard Stairs (4SC) Climb After 18 Months of Treatment | Givinostat | 1.27 | Standard Error 0.040 | seconds | |
| Mean Change From Baseline in 4 Standard Stairs (4SC) Climb After 18 Months of Treatment | Placebo | 1.48 | Standard Error 0.058 | seconds | |
| Mean Change From Baseline in Time to Rise From Floor After 18 Months of Treatment | Givinostat | 9.33 | 95% Confidence Interval 5.821 to 12.838 | seconds | |
| Mean Change From Baseline in Time to Rise From Floor After 18 Months of Treatment | Placebo | 12.61 | 95% Confidence Interval 7.491 to 17.724 | seconds | |
| Mean Change From Baseline in the Six-minute Walking Test (6MWT) After 18 Months of Treatment | Givinostat | -38.43 | 95% Confidence Interval -50.704 to -26.153 | meters | |
| Mean Change From Baseline in the Six-minute Walking Test (6MWT) After 18 Months of Treatment | Placebo | -48.38 | 95% Confidence Interval -66.288 to -30.482 | meters | |
| Mean Change From Baseline in Total North Star Ambulatory Assessment (NSAA) Score After 18 Months of Treatment | Givinostat | -2.66 | 95% Confidence Interval -3.563 to -1.759 | score on a scale | |
| Mean Change From Baseline in Total North Star Ambulatory Assessment (NSAA) Score After 18 Months of Treatment | Placebo | -4.58 | 95% Confidence Interval -5.891 to -3.260 | score on a scale | |
| Cumulative Loss of Function on the NSAA | Givinostat | 3.42 | 95% Confidence Interval 2.692 to 4.334 | cumulative number of failures | |
| Cumulative Loss of Function on the NSAA | Placebo | 5.56 | 95% Confidence Interval 4.002 to 7.715 | cumulative number of failures | |
| Mean Change From Baseline of Muscle Strength Normalized Overtime | Givinostat | Overall knee extension | -0.32 | 95% Confidence Interval -0.441 to -0.197 | Newtons/kg |
| Mean Change From Baseline of Muscle Strength Normalized Overtime | Placebo | Overall knee extension | -0.50 | 95% Confidence Interval -0.681 to -0.328 | Newtons/kg |
| Mean Change From Baseline of Muscle Strength Normalized Overtime | Givinostat | Overall elbow flexion | -0.10 | 95% Confidence Interval -0.174 to -0.031 | Newtons/kg |
| Mean Change From Baseline of Muscle Strength Normalized Overtime | Placebo | Overall elbow flexion | -0.19 | 95% Confidence Interval -0.292 to -0.085 | Newtons/kg |
| Mean Change From Baseline in Vastus Lateralis Muscle Fat Fraction (VL MFF) at 18 Months | Givinostat | 7.63 | 95% Confidence Interval 6.098 to 9.172 | percentage of fat | |
| Mean Change From Baseline in Vastus Lateralis Muscle Fat Fraction (VL MFF) at 18 Months | Placebo | 10.56 | 95% Confidence Interval 8.331 to 12.783 | percentage of fat | |
| Number of Subjects Experiencing Treatment-emergent AEs (TEAEs), Serious AEs (SAEs), Mild TEAE Moderate TEAE, Severe TEAE | Givinostat | Subjects with TEAE | 112 | Participants | |
| Number of Subjects Experiencing Treatment-emergent AEs (TEAEs), Serious AEs (SAEs), Mild TEAE Moderate TEAE, Severe TEAE | Placebo | Subjects with TEAE | 57 | Participants | |
| Number of Subjects Experiencing Treatment-emergent AEs (TEAEs), Serious AEs (SAEs), Mild TEAE Moderate TEAE, Severe TEAE | Givinostat | Subjects with serious AE | 8 | Participants | |
| Number of Subjects Experiencing Treatment-emergent AEs (TEAEs), Serious AEs (SAEs), Mild TEAE Moderate TEAE, Severe TEAE | Placebo | Subjects with serious AE | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02851797/results